2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow ASG-5ME: new trials by email Literature Review of ASG-5ME trials Research Report on ASG-5ME
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer ASG-5ME - Prostate Neoplasms | Phase 1 | Completed | Astellas Pharma Inc | 46 | 2010-10-01 | 2013-06-07 |
| A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma ASG-5ME - Gastric Neoplasms, Pancreatic Neoplasms | Phase 1 | Completed | Seagen Inc. | 51 | 2010-07-01 | 2013-08-27 |
Pancreatic Neoplasms (1) · Prostatic Neoplasms (1) · Stomach Neoplasms (1)
Astellas Pharma Inc (1) · Seagen Inc. (1)
United States (2)